Open Collections

TRIUMF: Canada's national laboratory for particle and nuclear physics

Progress during the first year of operation of the Batho Biomedical Facility at TRIUMF, October 1976 Henkelman, R. Mark; Lam, K. Y.; Harrison, R. W.; Shortt, Kenneth Robert, 1947-; Poon, Michael Nai-Chiu; Lang, H.; Jaggi, B. W; Palcic, B.; Skarsgard, L. D.

Abstract

The Batho Biomedical Facility at the TRIUMF accelerator is dedicated to an investigation of the efficacy of pion radiation for the clinical management of malignant disease. It has been constructed by the B.C. Cancer Foundation with financial assistance from the Health Resources Fund - under which it has been designated a Health Project of National Significance. A preclinical research programme designed to provide an adequate scientific base from which to initiate treatment is currently in progress, funded by the National Cancer Institute of Canada. Clinical investigation and patient trials will be conducted in collaboration with the Cancer Control Agency of British Columbia, which is responsible for all the management of malignant disease by radiation in the Province.

Item Metadata

Title
Progress during the first year of operation of the Batho Biomedical Facility at TRIUMF, October 1976
Alternate Title
TRIUMF brown reports TRI-77-2
Creator
Henkelman, R. Mark; Lam, K. Y.; Harrison, R. W.; Shortt, Kenneth Robert, 1947-; Poon, Michael Nai-Chiu; Lang, H.; Jaggi, B. W; Palcic, B.; Skarsgard, L. D.
Publisher
TRIUMF
Date Issued
1977-10
Description
The Batho Biomedical Facility at the TRIUMF accelerator is dedicated to an investigation of the efficacy of pion radiation for the clinical management of malignant disease. It has been constructed by the B.C. Cancer Foundation with financial assistance from the Health Resources Fund - under which it has been designated a Health Project of National Significance. A preclinical research programme designed to provide an adequate scientific base from which to initiate treatment is currently in progress, funded by the National Cancer Institute of Canada. Clinical investigation and patient trials will be conducted in collaboration with the Cancer Control Agency of British Columbia, which is responsible for all the management of malignant disease by radiation in the Province.
Subject
Pion radiation
Genre
Report
Type
Text
Language
eng
Date Available
2015-05-13
Provider
Vancouver : University of British Columbia Library
Rights
Attribution-NonCommercial-NoDerivs 2.5 Canada
DOI
10.14288/1.0107811
URI
http://hdl.handle.net/2429/53137
Affiliation
TRIUMF; Non UBC
Peer Review Status
Unreviewed
Scholarly Level
Researcher
Copyright Holder
TRIUMF
Rights URI
http://creativecommons.org/licenses/by-nc-nd/2.5/ca/
Aggregated Source Repository
DSpace

Item Media

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivs 2.5 Canada